Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Korea Genetic Pharm is a South Korean pharmaceutical company specializing in health functional foods, over-the-counter medicines, and medical devices. Established in 2002, the company has built a strong reputation for its research into natural extracts, particularly its flagship Maca-based supplement line, Maca-bo. In addition to nutritional supplements, the company produces portable oxygen products under the brand Oxy-up and various wellness-oriented pharmaceuticals. Korea Genetic Pharm maintains its own R&D center to innovate in the fields of natural substance extraction and health optimization. The company is headquartered in Seoul and operates manufacturing facilities in Gyeonggi-do. Its business model focuses on the commercialization of preventive healthcare solutions and vitality-enhancing products for the domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Korea Genetic Pharm.